Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 4
2003 4
2004 6
2005 5
2006 6
2007 15
2008 12
2009 14
2010 16
2011 11
2012 10
2013 6
2014 9
2015 21
2016 9
2017 5
2018 3
2019 4
2020 6
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
Carbonyl Compounds in Mainstream Smoke of Hemp Cigarettes.
Ward AM, Ebbert JO. Ward AM, et al. Among authors: ebbert jo. Cannabis Cannabinoid Res. 2021 Aug;6(4):349-357. doi: 10.1089/can.2020.0039. Epub 2020 Jul 28. Cannabis Cannabinoid Res. 2021. PMID: 33998857 Free PMC article.
Materials and Methods: We analyzed and compared carbonyl concentrations in the mainstream smoke produced by a hemp cigarette (Brand B), a premium hemp cigarette (Brand A), Marlboro Red tobacco cigarette, and a research reference tobacco cigarette using high-performa …
Materials and Methods: We analyzed and compared carbonyl concentrations in the mainstream smoke produced by a hemp cigarette (Brand B), a pr …
Electronic Vaping Product Use among Young Adults Who Receive Care at a Major Medical Institution.
Sharma P, Philpot LM, Rosedahl JK, Jose TT, Ebbert JO. Sharma P, et al. Among authors: ebbert jo. Subst Use Misuse. 2021;56(2):224-237. doi: 10.1080/10826084.2020.1853777. Epub 2020 Dec 23. Subst Use Misuse. 2021. PMID: 33356754
Ever EVP users had lower odds than never users to report that EVPs with nicotine are "a little" or "a lot" more harmful than smoking "regular" tobacco cigarettes (OR = 0.53, 95% CI 0.37 - 0.76). Conclusion: Our survey is limited by a low response rate but confirms observed …
Ever EVP users had lower odds than never users to report that EVPs with nicotine are "a little" or "a lot" more harmful than smoking "regula …
Changes in substance use among young adults during a respiratory disease pandemic.
Sharma P, Ebbert JO, Rosedahl JK, Philpot LM. Sharma P, et al. Among authors: ebbert jo. SAGE Open Med. 2020 Oct 14;8:2050312120965321. doi: 10.1177/2050312120965321. eCollection 2020. SAGE Open Med. 2020. PMID: 33133603 Free PMC article.
METHODS: Cross-sectional survey of young adults (18-25 years of age) assessing respondent characteristics and vaping, tobacco, alcohol, and/or marijuana use. We calculated prevalence estimates, prevalence changes, and prevalence ratios with associated 95% confidence interv …
METHODS: Cross-sectional survey of young adults (18-25 years of age) assessing respondent characteristics and vaping, tobacco, alcoho …
Electronic nicotine delivery system design and aerosol toxicants: A systematic review.
Ward AM, Yaman R, Ebbert JO. Ward AM, et al. Among authors: ebbert jo. PLoS One. 2020 Jun 4;15(6):e0234189. doi: 10.1371/journal.pone.0234189. eCollection 2020. PLoS One. 2020. PMID: 32497139 Free PMC article.
Findings were grouped into 6 major categories of potentially harmful chemicals: carbonyls, volatile organic chemicals, trace elements, reactive oxygen species and free radicals, polycyclic aromatic hydrocarbons, and tobacco-specific nitrosamines. In general, higher concent …
Findings were grouped into 6 major categories of potentially harmful chemicals: carbonyls, volatile organic chemicals, trace elements, react …
Influence of gender on initiation of tobacco and nicotine containing product use among U.S. Air Force trainees.
Patten CA, Wang XQ, Little MA, Ebbert JO, Talcott GW, Hryshko-Mullen AS, Klesges R. Patten CA, et al. Among authors: ebbert jo. Prev Med Rep. 2020 May 5;19:101104. doi: 10.1016/j.pmedr.2020.101104. eCollection 2020 Sep. Prev Med Rep. 2020. PMID: 32435579 Free PMC article.
Military personnel are a subgroup of young adults at risk for tobacco and nicotine containing product (TNCP) use. This study of US Air Force (USAF) trainees who were never users of TNCPs examined gender, peer tobacco use, and tobacco use intentions as predict …
Military personnel are a subgroup of young adults at risk for tobacco and nicotine containing product (TNCP) use. This study of US Ai …
Factors Associated with Cigarette Use During Airmen's First Year of Service in the United States Air Force.
Little M, Ebbert JO, Krukowski RA, Halbert J, Kalpinski MR, Patten CA, Talcott GW, Klesges RC. Little M, et al. Among authors: ebbert jo. Mil Med. 2020 Feb 12;185(1-2):e212-e220. doi: 10.1093/milmed/usz155. Mil Med. 2020. PMID: 31287888 Free PMC article.
Compared to former smokers who remained abstinent, the strongest predictor of re-initiation was intention to use tobacco (OR 2.08, 95% CI 1.53, 2.83). Compared to individuals who initiate, the strongest predictors of re-initiation were prior use of other tobacco
Compared to former smokers who remained abstinent, the strongest predictor of re-initiation was intention to use tobacco (OR 2.08, 95 …
Predicting smokeless tobacco initiation and re-initiation in the United States Air Force.
Dunkle A, Kalpinski R, Ebbert J, Talcott W, Klesges R, Little MA. Dunkle A, et al. Among authors: ebbert j. Addict Behav Rep. 2018 Nov 8;9:100142. doi: 10.1016/j.abrep.2018.11.001. eCollection 2019 Jun. Addict Behav Rep. 2018. PMID: 31193918 Free PMC article.
INTRODUCTION: Active Duty United States Air Force (USAF) members have substantially higher rates of smokeless tobacco (ST) use than the general population. METHODS: We longitudinally assessed demographics, tobacco use, intrapersonal factors, and interpersonal factor …
INTRODUCTION: Active Duty United States Air Force (USAF) members have substantially higher rates of smokeless tobacco (ST) use than t …
Predicting cigarette initiation and reinitiation among active duty United States Air Force recruits.
Little MA, Ebbert JO, Krukowski RA, Halbert JP, Kalpinski R, Patten CA, Boothe TL, Pasker CK, Klesges RC, Talcott GW. Little MA, et al. Among authors: ebbert jo. Subst Abus. 2019;40(3):340-343. doi: 10.1080/08897077.2019.1577678. Epub 2019 Mar 18. Subst Abus. 2019. PMID: 30883297 Free PMC article.
Background: The first year of military service in the United States Air Force (USAF) is a high-risk time for tobacco use. Previous studies have demonstrated the effectiveness of a tobacco ban during Basic Military Training (BMT). ...Results: One year after BMT, we o …
Background: The first year of military service in the United States Air Force (USAF) is a high-risk time for tobacco use. Previous st …
Influence of gender and peer tobacco use on tobacco use intentions after a period of involuntary tobacco abstinence among U.S. Air Force trainees.
Patten C, Wang XQ, Ebbert JO, Little MA, Talcott GW, Hryshko-Mullen AS, Klesges RC. Patten C, et al. Among authors: ebbert jo. Prev Med Rep. 2019 Jan 20;13:270-276. doi: 10.1016/j.pmedr.2019.01.004. eCollection 2019 Mar. Prev Med Rep. 2019. PMID: 30723662 Free PMC article.
This study examined gender, prior tobacco use, and social-environmental factors as predictors of intentions to use tobacco (cigarette smoking and/or smokeless tobacco [ST]) after a forced period of abstinence among U.S. ...Overall, 17% of the sample re …
This study examined gender, prior tobacco use, and social-environmental factors as predictors of intentions to use tobacco (ci …
Prevalence and correlates of dual tobacco use in cancer survivors.
Fahey MC, Bursac Z, Ebbert JO, Klesges RC, Little MA. Fahey MC, et al. Among authors: ebbert jo. Cancer Causes Control. 2019 Mar;30(3):217-223. doi: 10.1007/s10552-019-1132-6. Epub 2019 Jan 22. Cancer Causes Control. 2019. PMID: 30671688
PURPOSE: Tobacco use in cancer survivors remains a significant problem, however, the use of non-cigarette tobacco products (NCTPs) in this population is less understood. ...Targeting potential dual use of tobacco products, particularly cigarette …
PURPOSE: Tobacco use in cancer survivors remains a significant problem, however, the use of non-cigarette tobacco products
Correlates of smoking status in cancer survivors.
Little MA, Klesges RC, Bursac Z, Halbert JP, Ebbert J, Talcott GW, Weksler B. Little MA, et al. Among authors: ebbert j. J Cancer Surviv. 2018 Dec;12(6):828-834. doi: 10.1007/s11764-018-0720-x. Epub 2018 Oct 20. J Cancer Surviv. 2018. PMID: 30343442 Free PMC article.
Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT. Hurt RT, et al. Among authors: ebbert jo. Drug Alcohol Depend. 2018 Mar 1;184:12-17. doi: 10.1016/j.drugalcdep.2017.11.017. Epub 2018 Jan 2. Drug Alcohol Depend. 2018. PMID: 29324248 Free PMC article. Clinical Trial.
BACKGROUND: Tobacco use is prevalent among persons with alcohol abuse and dependence. ...
BACKGROUND: Tobacco use is prevalent among persons with alcohol abuse and dependence. ...
Controlled Substance Agreements for Opioids in a Primary Care Practice.
Philpot LM, Ramar P, Elrashidi MY, Mwangi R, North F, Ebbert JO. Philpot LM, et al. Among authors: ebbert jo. J Pharm Policy Pract. 2017 Sep 12;10:29. doi: 10.1186/s40545-017-0119-5. eCollection 2017. J Pharm Policy Pract. 2017. PMID: 28919978 Free PMC article.
. < 65 years, P < 0.0001), male gender (P = 0.0001), and used tobacco (P = 0.0002) received significantly higher MME/day. Patients with more co-morbidities (Charlson Comorbidity Index, CCI) received higher MME/day (CCI > 3 vs. ...

. < 65 years, P < 0.0001), male gender (P = 0.0001), and used tobacco (P = 0.0002) received significantly higher MME/day. Patie

Enhancing the efficacy of a smoking quit line in the military: Study rationale, design and methods of the Freedom quit line.
Little MA, Ebbert JO, Bursac Z, Talcott GW, Talley L, LeRoy KM, Womack CR, Hryshko-Mullen AS, Klesges RC. Little MA, et al. Among authors: ebbert jo. Contemp Clin Trials. 2017 Aug;59:51-56. doi: 10.1016/j.cct.2017.04.011. Epub 2017 May 4. Contemp Clin Trials. 2017. PMID: 28479219 Free PMC article. Clinical Trial. No abstract available.
Step Care treatment for smoking cessation.
Ebbert JO, Little MA, Klesges RC, Bursac Z, Johnson KC, Thomas F, Vander Weg MW. Ebbert JO, et al. Health Educ Res. 2017 Feb 1;32(1):1-11. doi: 10.1093/her/cyw051. Health Educ Res. 2017. PMID: 28158558 Free PMC article. Clinical Trial.
Step 1 of the Step Care intervention consisted of a single counseling session, nicotine patch for six weeks and telephonic contact. For smokers not achieving tobacco abstinence 6 months after randomization with Step 1, the intensity of the intervention increased to four co …
Step 1 of the Step Care intervention consisted of a single counseling session, nicotine patch for six weeks and telephonic contact. For smok …
Smokeless tobacco use among United States Air Force trainees.
Linde BD, Ebbert JO, Schroeder DR, Hanson AC, Talcott GW, Klesges RC. Linde BD, et al. Among authors: ebbert jo. Subst Abus. 2017 Jul-Sep;38(3):278-284. doi: 10.1080/08897077.2016.1275924. Epub 2016 Dec 27. Subst Abus. 2017. PMID: 28027011 Free PMC article.
Logistic regression was used to analyze the associations between demographic variables, tobacco use, and social factors for both regular and infrequent smokeless tobacco (e.g., chewing tobacco, snuff) users. ...Black or African Americans were less likely than …
Logistic regression was used to analyze the associations between demographic variables, tobacco use, and social factors for both regu …
Types of Dual and Poly-Tobacco Users in the US Military.
Little MA, Bursac Z, Derefinko KJ, Ebbert JO, Talcott GW, Hryshko-Mullen A, Klesges RC. Little MA, et al. Among authors: ebbert jo. Am J Epidemiol. 2016 Aug 1;184(3):211-8. doi: 10.1093/aje/kwv321. Epub 2016 Jul 15. Am J Epidemiol. 2016. PMID: 27421292 Free PMC article.
The assessment included prevalence of the use of 10 different tobacco products and demographic and environmental factors, such as risk perceptions of tobacco use, peer use, and tobacco-company influences. ...Latent class analysis indicated 5 classes of …
The assessment included prevalence of the use of 10 different tobacco products and demographic and environmental factors, such …
Reducing Childhood Tobacco Smoke Exposure.
Ebbert JO, Jacobson RM. Ebbert JO, et al. JAMA. 2016 Jun 21;315(23):2610-1. doi: 10.1001/jama.2016.6751. JAMA. 2016. PMID: 27327803 No abstract available.
Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.
Burke MV, Hays JT, Ebbert JO. Burke MV, et al. Among authors: ebbert jo. Patient Prefer Adherence. 2016 Apr 1;10:435-41. doi: 10.2147/PPA.S83469. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27099479 Free PMC article. Review.
Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability. Counseling and pharmacotherapy have been shown to increase tobacco abstinence rates among smokers. Varenicline is the most effective monotherapy treatment fo …
Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability. Counseling and pharmacot …
The safety of treatments for tobacco use disorder.
Little MA, Ebbert JO. Little MA, et al. Among authors: ebbert jo. Expert Opin Drug Saf. 2016;15(3):333-41. doi: 10.1517/14740338.2016.1131817. Epub 2015 Dec 30. Expert Opin Drug Saf. 2016. PMID: 26715118 Review.
INTRODUCTION: Tobacco continues to be a leading cause of preventable morbidity and mortality in the world. First-line pharmacotherapies for the treatment of tobacco use disorder include nicotine replacement therapy, bupropion sustained-release (SR), and varenicline. …
INTRODUCTION: Tobacco continues to be a leading cause of preventable morbidity and mortality in the world. First-line pharmacotherapi …
A Critical Review of Repurposing Apomorphine for Smoking Cessation.
Morales-Rosado JA, Cousin MA, Ebbert JO, Klee EW. Morales-Rosado JA, et al. Among authors: ebbert jo. Assay Drug Dev Technol. 2015 Dec;13(10):612-22. doi: 10.1089/adt.2015.680. Assay Drug Dev Technol. 2015. PMID: 26690764 Review.
The focus of this review is to evaluate the potential role of apomorphine (APO) in treating tobacco dependence. Previously described in the literature as a non-specific dopamine agonist effective in treating Parkinson's disease and erectile dysfunction, APO's
The focus of this review is to evaluate the potential role of apomorphine (APO) in treating tobacco dependence. Previously described …
Treatment Outcomes From a Specialist Model for Treating Tobacco Use Disorder in a Medical Center.
Burke MV, Ebbert JO, Schroeder DR, McFadden DD, Hays JT. Burke MV, et al. Among authors: ebbert jo. Medicine (Baltimore). 2015 Nov;94(44):e1903. doi: 10.1097/MD.0000000000001903. Medicine (Baltimore). 2015. PMID: 26554789 Free PMC article.
The univariate association of each baseline patient characteristic with self-reported tobacco abstinence at 6 months was evaluated using the chi-squared test. ...While this study has limitations inherent in a single-center retrospective cohort study, it does suggest that t …
The univariate association of each baseline patient characteristic with self-reported tobacco abstinence at 6 months was evaluated us …
Efficacy of a Brief Tobacco Intervention for Tobacco and Nicotine Containing Product Use in the US Air Force.
Little MA, Talcott GW, Bursac Z, Linde BD, Pagano LA, Messler EC, Ebbert JO, Klesges RC. Little MA, et al. Among authors: ebbert jo. Nicotine Tob Res. 2016 May;18(5):1142-9. doi: 10.1093/ntr/ntv242. Epub 2015 Oct 27. Nicotine Tob Res. 2016. PMID: 26508394
INTRODUCTION: While effective Brief Tobacco Interventions (BTIs) are available for cigarette smoking and smokeless tobacco, given the changing prevalence of tobacco and nicotine containing products (TNCPs), there is a need for interventions targeting a …
INTRODUCTION: While effective Brief Tobacco Interventions (BTIs) are available for cigarette smoking and smokeless tobacco, gi …
Interventions for smokeless tobacco use cessation.
Ebbert JO, Elrashidi MY, Stead LF. Ebbert JO, et al. Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD004306. doi: 10.1002/14651858.CD004306.pub5. Cochrane Database Syst Rev. 2015. PMID: 26501380 Free PMC article. Review.
BACKGROUND: Use of smokeless tobacco (ST) can lead to tobacco dependence and long-term use can lead to health problems including periodontal disease, cancer, and cerebrovascular and cardiovascular disease. OBJECTIVES: To assess the effects of behavioural and pharmac …
BACKGROUND: Use of smokeless tobacco (ST) can lead to tobacco dependence and long-term use can lead to health problems includi …
Connecting low-income smokers to tobacco treatment services.
Slater JS, Nelson CL, Parks MJ, Ebbert JO. Slater JS, et al. Among authors: ebbert jo. Addict Behav. 2016 Jan;52:108-14. doi: 10.1016/j.addbeh.2015.10.013. Epub 2015 Oct 18. Addict Behav. 2016. PMID: 26489597
The current paper evaluates primary implementation and follow-up results of two strategies for connecting low-income, predominantly female smokers to a telephone tobacco quitline (QL). The population-based program consisted of participant-initiated phone contact and two re …
The current paper evaluates primary implementation and follow-up results of two strategies for connecting low-income, predominantly female s …
Efficacy of a Tobacco Quitline in Active Duty Military and TRICARE Beneficiaries: A Randomized Trial.
Klesges RC, Ebbert JO, Talcott GW, Thomas F, Richey PA, Womack C, Hryshko-Mullen A, Oh J. Klesges RC, et al. Among authors: ebbert jo. Mil Med. 2015 Aug;180(8):917-25. doi: 10.7205/MILMED-D-14-00513. Mil Med. 2015. PMID: 26226536 Clinical Trial.
A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have been conducted in the U.S. military. We evaluated the efficacy of a tobacco quitline (QL) in 1298 active duty military personnel …
A higher proportion of military personnel than civilians smoke cigarettes. Few randomized trials of tobacco use interventions have be …
Tobacco Research in the Military: Reflections on 20 Years of Research in the United States Air Force.
Talcott GW, Ebbert JO, Klesges RC, Linde BD, Seals RW, Krukowski RA, Grieser EA, Oh JY, Martin-Zona DM. Talcott GW, et al. Among authors: ebbert jo. Mil Med. 2015 Aug;180(8):848-50. doi: 10.7205/MILMED-D-14-00501. Mil Med. 2015. PMID: 26226525 Free PMC article. Review.
The U.S. military is one of the world's largest employers. Approximately 30% of active duty military personnel smoke cigarettes and more than 14% use smokeless tobacco. ...Our findings may provide groundwork for future tobacco control efforts in the U. …
The U.S. military is one of the world's largest employers. Approximately 30% of active duty military personnel smoke cigarette …
Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
Ebbert JO, Severson HH, Danaher BG, Benowitz NL, Schroeder DR. Ebbert JO, et al. Nicotine Tob Res. 2016 Mar;18(3):366-70. doi: 10.1093/ntr/ntv102. Epub 2015 May 14. Nicotine Tob Res. 2016. PMID: 25977408 Free PMC article. Clinical Trial.
We evaluated whether the NMR can be used to predict self-reported nicotine lozenge use and tobacco abstinence among smokeless tobacco users treated for tobacco dependence. ...The NMR was not significantly correlated with the baseline amount of smokeless to
We evaluated whether the NMR can be used to predict self-reported nicotine lozenge use and tobacco abstinence among smokeless toba
The Prevalence of E-cigarette Use in a Sample of U.S. Air Force Recruits.
Little MA, Derefinko KJ, Colvin L, Ebbert JO, Bursac Z, Talcott GW, Richey PA, Klesges RC. Little MA, et al. Among authors: ebbert jo. Am J Prev Med. 2015 Sep;49(3):402-8. doi: 10.1016/j.amepre.2015.02.019. Epub 2015 Apr 18. Am J Prev Med. 2015. PMID: 25896193 Free PMC article.
The purpose of the current study is to provide recent (2013-2014) data on the prevalence of regular e-cigarette use in a population of recruits prior to their entry into the U.S. military. METHODS: The study utilized a cross-sectional assessment of e-cigarette and other …
The purpose of the current study is to provide recent (2013-2014) data on the prevalence of regular e-cigarette use in a population of recru …
Prevalence and Correlates of Tobacco and Nicotine Containing Product Use in a Sample of United States Air Force Trainees.
Little MA, Derefinko KJ, Bursac Z, Ebbert JO, Colvin L, Talcott GW, Hryshko-Mullen AS, Richey PA, Klesges RC. Little MA, et al. Among authors: ebbert jo. Nicotine Tob Res. 2016 Apr;18(4):416-23. doi: 10.1093/ntr/ntv090. Epub 2015 Apr 20. Nicotine Tob Res. 2016. PMID: 25895952 Free PMC article.
INTRODUCTION: Although there is increasing attention to the prevalence of new and emerging tobacco products in the civilian population, remarkably little is known about the current prevalence of these products in a military population. METHODS: The current in …
INTRODUCTION: Although there is increasing attention to the prevalence of new and emerging tobacco products in the civilian po …
Prevalence and predictors of hookah use in US Air Force military recruits.
Linde BD, Ebbert JO, Pasker CK, Wayne Talcott G, Schroeder DR, Hanson AC, Klesges RC. Linde BD, et al. Among authors: ebbert jo. Addict Behav. 2015 Aug;47:5-10. doi: 10.1016/j.addbeh.2015.03.012. Epub 2015 Mar 21. Addict Behav. 2015. PMID: 25841088 Free PMC article.
INTRODUCTION: Hookah use has gained recent popularity among U.S. youth. The current study describes the characteristics and correlates associated with hookah use in late adolescent and young adult US Air Force (USAF) recruits. ...Logistic regression was used to analyze the …
INTRODUCTION: Hookah use has gained recent popularity among U.S. youth. The current study describes the characteristics and correlate …
Quit_line treatment protocols for users of non-cigarette tobacco and nicotine containing products.
Linde BD, Ebbert JO, Talcott GW, Klesges RC. Linde BD, et al. Among authors: ebbert jo. Addict Behav. 2015 Jun;45:259-62. doi: 10.1016/j.addbeh.2015.02.015. Epub 2015 Feb 21. Addict Behav. 2015. PMID: 25746358
INTRODUCTION: Use of non-cigarette tobacco and nicotine containing products (TNCPs) is increasing in the US. ...Only one QL (9.1%) had a specialized protocol for smokeless tobacco users in addition to a standard protocol for all other callers. ...
INTRODUCTION: Use of non-cigarette tobacco and nicotine containing products (TNCPs) is increasing in the US. ...Only one QL (9 …
Female smokers have the highest alcohol craving in a residential alcoholism treatment cohort.
Hitschfeld MJ, Schneekloth TD, Ebbert JO, Hall-Flavin DK, Karpyak VM, Abulseoud OA, Patten CA, Geske JR, Frye MA. Hitschfeld MJ, et al. Among authors: ebbert jo. Drug Alcohol Depend. 2015 May 1;150:179-82. doi: 10.1016/j.drugalcdep.2015.02.016. Epub 2015 Feb 25. Drug Alcohol Depend. 2015. PMID: 25746235
Demographic and clinical variables were collected including smoking status, alcohol craving utilizing the Penn Alcohol Craving Scale (PACS), and alcohol relapse. Statistical analyses included Chi-square, ANOVA, Tukey's test, Kaplan-Meier plots and Cox proportional hazards …
Demographic and clinical variables were collected including smoking status, alcohol craving utilizing the Penn Alcohol Craving Scale (PACS), …
Counseling patients on the use of electronic cigarettes.
Ebbert JO, Agunwamba AA, Rutten LJ. Ebbert JO, et al. Mayo Clin Proc. 2015 Jan;90(1):128-34. doi: 10.1016/j.mayocp.2014.11.004. Mayo Clin Proc. 2015. PMID: 25572196 Free article. Review.
Clear evidence about the safety of e-cigarettes is lacking, and laboratory experiments and case reports suggest these products may be associated with potential adverse health consequences. The effectiveness of e-cigarettes for smoking cessation is modest and appears to be …
Clear evidence about the safety of e-cigarettes is lacking, and laboratory experiments and case reports suggest these products may be …
Designation of obesity as a disease: lessons learned from alcohol and tobacco.
Hurt RT, Edakkanambeth Varayil J, Mundi MS, Martindale RG, Ebbert JO. Hurt RT, et al. Among authors: ebbert jo. Curr Gastroenterol Rep. 2014 Nov;16(11):415. doi: 10.1007/s11894-014-0415-z. Curr Gastroenterol Rep. 2014. PMID: 25277042 Review.
This declaration had the intention of improving screening and long-term treatment and is historically similar to the designation of tobacco and alcohol dependence as a chronic disease. Nevertheless, it has ignited a nationwide debate in both academia and public opinion. .. …
This declaration had the intention of improving screening and long-term treatment and is historically similar to the designation of tobac
Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation.
Severson HH, Danaher BG, Ebbert JO, van Meter N, Lichtenstein E, Widdop C, Crowley R, Akers L, Seeley JR. Severson HH, et al. Among authors: ebbert jo. Nicotine Tob Res. 2015 Mar;17(3):309-15. doi: 10.1093/ntr/ntu145. Epub 2014 Aug 28. Nicotine Tob Res. 2015. PMID: 25168034 Free PMC article. Clinical Trial.
Additionally, all participants were mailed self-help materials. Self-reported tobacco abstinence was assessed at 3 and 6 months after randomization. ...The study confirms the high tobacco abstinence rates for self-help ST cessation interventions and offers guidance …
Additionally, all participants were mailed self-help materials. Self-reported tobacco abstinence was assessed at 3 and 6 months after …
Accuracy of self-reported tobacco use status among hematopoietic SCT patients.
Ehlers SL, Bronars CA, Patten CA, Brockman T, Hughes C, Decker PA, Cerhan JR, Hogan W, Dispenzieri A, Ansell S, Ebbert J, Gastineau D. Ehlers SL, et al. Among authors: ebbert j. Bone Marrow Transplant. 2014 Jul;49(7):961-5. doi: 10.1038/bmt.2014.70. Epub 2014 Apr 14. Bone Marrow Transplant. 2014. PMID: 24732958 Free PMC article.
Tobacco use is a risk factor for adverse outcomes among hematopoietic SCT (HSCT) patients. Accurate identification of tobacco use offers a vital opportunity to treat this risk factor. ...
Tobacco use is a risk factor for adverse outcomes among hematopoietic SCT (HSCT) patients. Accurate identification of tobacco
Dual tobacco user subtypes in the U.S. Air Force: dependence, attitudes, and other correlates of use.
Kram Y, Klesges RC, Ebbert JO, Talcott W, Neilands TB, Ling PM. Kram Y, et al. Among authors: ebbert jo. Nicotine Tob Res. 2014 Sep;16(9):1216-23. doi: 10.1093/ntr/ntu056. Epub 2014 Apr 10. Nicotine Tob Res. 2014. PMID: 24721813 Free PMC article.
INTRODUCTION: To describe the characteristics associated with patterns of daily and dual tobacco use among U.S. Air Force (USAF) personnel transitioning from basic military training to technical training. ...RESULTS: Compared to daily smokers, participants who were …
INTRODUCTION: To describe the characteristics associated with patterns of daily and dual tobacco use among U.S. Air Force (USA …
Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.
Cousin MA, Ebbert JO, Wiinamaki AR, Urban MD, Argue DP, Ekker SC, Klee EW. Cousin MA, et al. Among authors: ebbert jo. PLoS One. 2014 Mar 21;9(3):e90467. doi: 10.1371/journal.pone.0090467. eCollection 2014. PLoS One. 2014. PMID: 24658307 Free PMC article.
Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of death among alcoholics. Long-term tobacco abstinence rates are low, and pharmacotherapeutic options are limited. Repositioning medicat …
Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of d …
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Elrashidi MY, Ebbert JO. Elrashidi MY, et al. Among authors: ebbert jo. Expert Opin Emerg Drugs. 2014 Jun;19(2):243-60. doi: 10.1517/14728214.2014.899580. Epub 2014 Mar 22. Expert Opin Emerg Drugs. 2014. PMID: 24654737 Review.
INTRODUCTION: Tobacco dependence remains a global epidemic and the largest preventable cause of morbidity and mortality around the world. ...AREAS COVERED: This review summarizes current and emerging pharmacotherapies for the treatment of tobacco dependence, includi …
INTRODUCTION: Tobacco dependence remains a global epidemic and the largest preventable cause of morbidity and mortality around the wo …
Preventing smoking initiation or relapse following 8.5 weeks of involuntary smoking abstinence in basic military training: trial design, interventions, and baseline data.
Brandon TH, Klesges RC, Ebbert JO, Talcott GW, Thomas F, Leroy K, Richey PA, Colvin L. Brandon TH, et al. Among authors: ebbert jo. Contemp Clin Trials. 2014 May;38(1):28-36. doi: 10.1016/j.cct.2014.03.001. Epub 2014 Mar 15. Contemp Clin Trials. 2014. PMID: 24637237 Free PMC article. Clinical Trial.
During basic military training (BMT), tobacco use is strictly forbidden in all service branches, but tobacco relapse (and initiation) following BMT is extremely high. ...Participants are randomized by squadron to receive either a standard smoking-cessation booklet, …
During basic military training (BMT), tobacco use is strictly forbidden in all service branches, but tobacco relapse (and init …
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD. Ebbert JO, et al. JAMA. 2014 Jan 8;311(2):155-63. doi: 10.1001/jama.2013.283185. JAMA. 2014. PMID: 24399554 Free PMC article. Clinical Trial.
IMPORTANCE: Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstinence. OBJECTIVE: To determine efficacy and safety of varenicline and bupropion sustained-release (SR; combination therapy) compared with varenicline (monotherapy) in cigaret …
IMPORTANCE: Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstinence. OBJECTIVE: To determine eff …
A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.
Ebbert JO, Croghan IT, Schroeder DR, Hurt RD. Ebbert JO, et al. Nicotine Tob Res. 2013 Dec;15(12):2037-44. doi: 10.1093/ntr/ntt097. Epub 2013 Jul 19. Nicotine Tob Res. 2013. PMID: 23873976 Free PMC article. Clinical Trial.
INTRODUCTION: Nicotine patch therapy has not been shown to be efficacious for increasing long-term (6 months) tobacco abstinence rates among smokeless tobacco (ST) users. Higher doses of nicotine patch therapy may be needed to increase tobacco abstinence rate …
INTRODUCTION: Nicotine patch therapy has not been shown to be efficacious for increasing long-term (6 months) tobacco abstinence rate …
Smoking bans research--reply.
Hurt RD, Roger VL, Ebbert JO. Hurt RD, et al. Among authors: ebbert jo. JAMA Intern Med. 2013 May 13;173(9):836-7. doi: 10.1001/jamainternmed.2013.928. JAMA Intern Med. 2013. PMID: 23700023 No abstract available.
Cigarette smoking in methadone maintained patients: an up-to-date review.
Zirakzadeh A, Shuman C, Stauter E, Hays JT, Ebbert JO. Zirakzadeh A, et al. Among authors: ebbert jo. Curr Drug Abuse Rev. 2013 Mar;6(1):77-84. doi: 10.2174/1874473711306010009. Curr Drug Abuse Rev. 2013. PMID: 23506370 Review.
Tobacco dependence is the leading cause of preventable death and disability in the United States. While smoking prevalence among U.S. adults is 19.3%, the prevalence of smoking among methadone-maintained patients ranges between 73.5% and 94%. ...
Tobacco dependence is the leading cause of preventable death and disability in the United States. While smoking prevalence among U.
Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR. Ebbert JO, et al. Addict Behav. 2013 May;38(5):2140-5. doi: 10.1016/j.addbeh.2013.01.023. Epub 2013 Feb 4. Addict Behav. 2013. PMID: 23454876 Free PMC article. Clinical Trial.
Previous studies have evaluated the effectiveness of nicotine lozenges and tobacco-free snuff for reducing ST use among ST users not ready to quit, but no comparative effectiveness trials of these two products have been conducted. ...Participants received 8 weeks of …
Previous studies have evaluated the effectiveness of nicotine lozenges and tobacco-free snuff for reducing ST use among ST users not …
Tobacco use during military deployment.
Talcott GW, Cigrang J, Sherrill-Mittleman D, Snyder DK, Baker M, Tatum J, Cassidy D, Sonnek S, Balderrama-Durbin C, Klesges RC, Ebbert JO, Slep AM, Heyman RE. Talcott GW, et al. Among authors: ebbert jo. Nicotine Tob Res. 2013 Aug;15(8):1348-54. doi: 10.1093/ntr/nts267. Epub 2013 Jan 8. Nicotine Tob Res. 2013. PMID: 23299184
METHOD: Cigarette smoking, smokeless tobacco (ST) use, and dual tobacco use were evaluated among 278U.S. ...Airmen who had deployed more than once previously had a higher likelihood of using ST use at predeployment and engaging in dual tobacco use duri …
METHOD: Cigarette smoking, smokeless tobacco (ST) use, and dual tobacco use were evaluated among 278U.S. ...Airmen who …
S-adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial.
Sood A, Prasad K, Croghan IT, Schroeder DR, Ehlers SL, Ebbert JO. Sood A, et al. Among authors: ebbert jo. J Altern Complement Med. 2012 Sep;18(9):854-9. doi: 10.1089/acm.2011.0462. Epub 2012 Aug 17. J Altern Complement Med. 2012. PMID: 22901308 Free PMC article. Clinical Trial.
OBJECTIVES: S-Adenosyl-L-methionine (SAMe) is a dietary supplement commonly used to treat depression. ...CONCLUSIONS: SAMe did not increase smoking abstinence rates. Abstinence and tobacco withdrawal data from this clinical trial suggest that SAMe holds little promi …
OBJECTIVES: S-Adenosyl-L-methionine (SAMe) is a dietary supplement commonly used to treat depression. ...CONCLUSIONS: SAMe did not in …
A comparison of three smokeless tobacco dependence measures.
Ebbert JO, Severson HH, Danaher BG, Schroeder DR, Glover ED. Ebbert JO, et al. Addict Behav. 2012 Nov;37(11):1271-7. doi: 10.1016/j.addbeh.2012.06.011. Epub 2012 Jun 21. Addict Behav. 2012. PMID: 22762958 Free PMC article. Clinical Trial.
Smokeless tobacco (ST) use is associated with tobacco dependence and long-term adverse health consequences. ...We used data from a study evaluating the effectiveness of bupropion sustained release for the treatment of ST use (N=225) to compare the Fagerstrom Toleran …
Smokeless tobacco (ST) use is associated with tobacco dependence and long-term adverse health consequences. ...We used data fr …
Interventions for tobacco cessation in the dental setting.
Carr AB, Ebbert J. Carr AB, et al. Among authors: ebbert j. Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD005084. doi: 10.1002/14651858.CD005084.pub3. Cochrane Database Syst Rev. 2012. PMID: 22696348 Free PMC article. Updated. Review.
BACKGROUND: Tobacco use has significant adverse effects on oral health. Oral health professionals in the dental office or community setting have a unique opportunity to increase tobacco abstinence rates among tobacco users. ...AUTHORS' CONCLUSIONS: Available …
BACKGROUND: Tobacco use has significant adverse effects on oral health. Oral health professionals in the dental office or community s …
Tobacco dependence counseling in a randomized multisite clinical trial.
Croghan IT, Trautman JA, Winhusen T, Ebbert JO, Kropp FB, Schroeder DR, Hurt RD. Croghan IT, et al. Among authors: ebbert jo. Contemp Clin Trials. 2012 Jul;33(4):576-82. doi: 10.1016/j.cct.2012.02.014. Epub 2012 Mar 3. Contemp Clin Trials. 2012. PMID: 22406192 Free PMC article. Clinical Trial.
Pharmacotherapy trials for treating tobacco dependence would benefit from behavioral interventions providing treatment consistent with clinical practice guidelines but not directing participants to treatments not evaluated in the trial. ...
Pharmacotherapy trials for treating tobacco dependence would benefit from behavioral interventions providing treatment consistent wit …
Use of smoking reduction strategies among U.S. tobacco quitlines.
Asfar T, Ebbert JO, Klesges RC, Klosky JL. Asfar T, et al. Among authors: ebbert jo. Addict Behav. 2012 Apr;37(4):583-6. doi: 10.1016/j.addbeh.2012.01.018. Epub 2012 Jan 25. Addict Behav. 2012. PMID: 22301531
INTRODUCTION: Tobacco quitlines (QLs) are efficacious and have assisted many smokers in achieving tobacco abstinence. ...Tobacco QLs service providers were identified through the North American Quitline Consortium (NAQC). ...
INTRODUCTION: Tobacco quitlines (QLs) are efficacious and have assisted many smokers in achieving tobacco abstinence. ...To
Pharmacological interventions for the treatment of smokeless tobacco use.
Ebbert JO, Fagerstrom K. Ebbert JO, et al. CNS Drugs. 2012 Jan 1;26(1):1-10. doi: 10.2165/11598450-000000000-00000. CNS Drugs. 2012. PMID: 22136150 Review.
Smokeless tobacco (SLT) is used in a variety of forms throughout the world. ...Nicotine replacement therapy (NRT) has been demonstrated to increase short-term tobacco abstinence rates and to alleviate craving and withdrawal symptoms among SLT users trying to quit. . …
Smokeless tobacco (SLT) is used in a variety of forms throughout the world. ...Nicotine replacement therapy (NRT) has been demonstrat …
Preventing lung cancer by treating tobacco dependence.
Hurt RD, Ebbert JO, Hays JT, McFadden DD. Hurt RD, et al. Among authors: ebbert jo. Clin Chest Med. 2011 Dec;32(4):645-57. doi: 10.1016/j.ccm.2011.08.004. Clin Chest Med. 2011. PMID: 22054877 Review.
Tobacco use is a chronic medical disorder. Providing evidence-based treatment of tobacco-dependent patients is a challenge, and a team approach provides an efficient treatment model. Tobacco treatment specialists could expand the collective tobacco tre
Tobacco use is a chronic medical disorder. Providing evidence-based treatment of tobacco-dependent patients is a challenge, an
Pharmacologic agents for tobacco dependence treatment: 2011 update.
Hays JT, McFadden DD, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. Curr Atheroscler Rep. 2012 Feb;14(1):85-92. doi: 10.1007/s11883-011-0211-2. Curr Atheroscler Rep. 2012. PMID: 22002681 Review.
If the current tobacco pandemic continues for another 20 years, the annual global tobacco-attributable mortality will exceed 8 million. In the US and many European countries, public health and tobacco control efforts combined with effective tobacco dep …
If the current tobacco pandemic continues for another 20 years, the annual global tobacco-attributable mortality will exceed 8 …
Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.
Hurt RD, Ebbert JO, Achadi A, Croghan IT. Hurt RD, et al. Among authors: ebbert jo. Tob Control. 2012 May;21(3):306-12. doi: 10.1136/tc.2010.036814. Epub 2011 Aug 18. Tob Control. 2012. PMID: 21852413 Free PMC article.
BACKGROUND: Indonesia is the world's fifth largest cigarette market in the world but for decades, transnational tobacco companies (TTCs) have had limited success infiltrating this market, due to their inability to compete in the kretek market. ...METHODS: We analyze …
BACKGROUND: Indonesia is the world's fifth largest cigarette market in the world but for decades, transnational tobacco compan …
Lessons learned on the road to a smoke-free Italy.
Croghan I, Muggli M, Zagà V, Lockhart N, Ebbert J, Mangiaracina G, Hurt R. Croghan I, et al. Among authors: ebbert j. Ann Ig. 2011 Mar-Apr;23(2):125-36. Ann Ig. 2011. PMID: 21770229 Free PMC article.
In the face of strong and protracted opposition by the Tobacco Industry (TI) and its allies, Italy's national smoke-free legislation came into force in 2005 prohibiting smoking in all indoor public places and workplaces including offices, bars, and restaurants. Usin …
In the face of strong and protracted opposition by the Tobacco Industry (TI) and its allies, Italy's national smoke-free legis …
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
Ebbert JO, Croghan IT, Severson HH, Schroeder DR, Hays JT. Ebbert JO, et al. Nicotine Tob Res. 2011 Sep;13(9):820-6. doi: 10.1093/ntr/ntr078. Epub 2011 Apr 18. Nicotine Tob Res. 2011. PMID: 21504885 Free PMC article. Clinical Trial.
INTRODUCTION: Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. ...CONCLUSIONS: Varenicline decreases craving and may be effective for increasing tobacco abstinence rates among ST users. Larger tri …
INTRODUCTION: Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. …
Impact of differing definitions of dual tobacco use: implications for studying dual use and a call for operational definitions.
Klesges RC, Ebbert JO, Morgan GD, Sherrill-Mittleman D, Asfar T, Talcott WG, Debon M. Klesges RC, et al. Among authors: ebbert jo. Nicotine Tob Res. 2011 Jul;13(7):523-31. doi: 10.1093/ntr/ntr032. Epub 2011 Mar 24. Nicotine Tob Res. 2011. PMID: 21436298 Free PMC article. Review.
We defined dual use as cigarette and smokeless tobacco (ST) consumption with either product used daily or nondaily. METHODS: We analyzed a cohort of 36,013 Air Force recruits. We categorized dual tobacco use across 2 dimensions, type of tobacco products
We defined dual use as cigarette and smokeless tobacco (ST) consumption with either product used daily or nondaily. METHODS: We analy …
Zebrafish for the study of the biological effects of nicotine.
Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC. Klee EW, et al. Among authors: ebbert jo. Nicotine Tob Res. 2011 May;13(5):301-12. doi: 10.1093/ntr/ntr010. Epub 2011 Mar 8. Nicotine Tob Res. 2011. PMID: 21385906 Free PMC article. Review.
Data are presented on the complete homology of all known human neural nicotinic acetylcholine receptors in zebrafish and on the biological similarity of human and zebrafish dopaminergic signaling. CONCLUSIONS: Tobacco dependence remains a major health problem worldwide. Fu …
Data are presented on the complete homology of all known human neural nicotinic acetylcholine receptors in zebrafish and on the biological s …
Interventions for smokeless tobacco use cessation.
Ebbert J, Montori VM, Erwin PJ, Stead LF. Ebbert J, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD004306. doi: 10.1002/14651858.CD004306.pub4. Cochrane Database Syst Rev. 2011. PMID: 21328266 Updated. Review.
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease, cancer, and cerebrovascular and cardiovascular disease. ...Nicotine replacement therapy (patch, gum, and lozenge) was not o …
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including peri …
Residential treatment compared with outpatient treatment for tobacco use and dependence.
Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD. Hays JT, et al. Among authors: ebbert jo. Mayo Clin Proc. 2011 Mar;86(3):203-9. doi: 10.4065/mcp.2010.0703. Epub 2011 Feb 9. Mayo Clin Proc. 2011. PMID: 21307389 Free PMC article.
OBJECTIVE: To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice. PATIENTS AND METHODS: We analyzed data from 2 cohorts of cigarette smokers who received either comprehensive outpatient or intensive 8-day re …
OBJECTIVE: To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice. P …
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.
Hurt RD, Ebbert JO, Croghan IT, Schroeder DR, Sood A, Hays JT. Hurt RD, et al. Among authors: ebbert jo. J Negat Results Biomed. 2011 Jan 28;10:1. doi: 10.1186/1477-5751-10-1. J Negat Results Biomed. 2011. PMID: 21276244 Free PMC article. Clinical Trial.
Although there are biologically plausible hypotheses that support the use of OROS-MPH for treating tobacco dependence, we found no evidence to support such hypotheses. In addition to no increase in smoking abstinence, we saw no effect of OROS-MPH for tobacco withdra …
Although there are biologically plausible hypotheses that support the use of OROS-MPH for treating tobacco dependence, we found no ev …
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Drugs. 2010. PMID: 21142259 Review.
Tobacco use is the leading cause of preventable death and disability in the world. ...Over half of all long-term smokers will die of a tobacco-related disease and the risk of a serious or life-threatening adverse event with tobacco cessation pharmacotherapy i
Tobacco use is the leading cause of preventable death and disability in the world. ...Over half of all long-term smokers will die of
Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.
Croghan IT, Hurt RD, Ebbert JO, Croghan GA, Polk OD, Stella PJ, Novotny PJ, Sloan J, Loprinzi CL. Croghan IT, et al. Among authors: ebbert jo. Z Gesundh Wiss. 2010 Feb;18(1):59-68. doi: 10.1007/s10389-009-0277-2. Epub 2009 Aug 11. Z Gesundh Wiss. 2010. PMID: 21088690 Free PMC article.

Factors associated with an increased likelihood of smoking were higher tobacco dependence scores (OR = 1.244, p < 0.0001), prior quit attempts (OR = 1.812, p = 0.004), and being a minority (OR = 1.849, p = 0.0083). ...CONCLUSION: Regardless of the treatment used, minori

Factors associated with an increased likelihood of smoking were higher tobacco dependence scores (OR = 1.244, p < 0.0001), prior q

Tobacco use harm reduction, elimination, and escalation in a large military cohort.
Klesges RC, Sherrill-Mittleman D, Ebbert JO, Talcott GW, Debon M. Klesges RC, et al. Among authors: ebbert jo. Am J Public Health. 2010 Dec;100(12):2487-92. doi: 10.2105/AJPH.2009.175091. Am J Public Health. 2010. PMID: 21068420 Free PMC article.
OBJECTIVES: We evaluated changing patterns of tobacco use following a period of forced tobacco abstinence in a US military cohort to determine rates of harm elimination (e.g., tobacco cessation), harm reduction (e.g., from smoking to smokeless tobacco
OBJECTIVES: We evaluated changing patterns of tobacco use following a period of forced tobacco abstinence in a US military coh …
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.
Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD. Ebbert JO, et al. Patient Prefer Adherence. 2010 Oct 5;4:355-62. doi: 10.2147/ppa.s10620. Patient Prefer Adherence. 2010. PMID: 21049087 Free PMC article.
Varenicline is the most recent addition to the pharmacotherapeutic armamentarium for the treatment of tobacco dependence. Varenicline is efficacious and cost-effective. ...
Varenicline is the most recent addition to the pharmacotherapeutic armamentarium for the treatment of tobacco dependence. Varenicline …
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Hays JT, Croghan IT, Schroeder DR, Ebbert JO, Hurt RD. Hays JT, et al. Among authors: ebbert jo. J Subst Abuse Treat. 2011 Jan;40(1):102-7. doi: 10.1016/j.jsat.2010.08.009. Epub 2010 Oct 13. J Subst Abuse Treat. 2011. PMID: 20947286 Clinical Trial.
No serious adverse events were reported. Varenicline may be a useful aid for treating tobacco dependence among smokers who are in stable recovery from alcohol dependence. ...
No serious adverse events were reported. Varenicline may be a useful aid for treating tobacco dependence among smokers who are in sta …
A pilot study to assess smokeless tobacco use reduction with varenicline.
Ebbert JO, Croghan IT, North F, Schroeder DR. Ebbert JO, et al. Nicotine Tob Res. 2010 Oct;12(10):1037-40. doi: 10.1093/ntr/ntq134. Epub 2010 Aug 19. Nicotine Tob Res. 2010. PMID: 20724382 Free PMC article. Clinical Trial.
INTRODUCTION: Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. ...At end of treatment (12 weeks), 60% (12/20) of subjects reduced their ST use by 50% and 15% (3/20) were biochemically confirmed abstinent …
INTRODUCTION: Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. …
Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.
Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Mills EJ, et al. Among authors: ebbert jo. Tob Induc Dis. 2010 Jul 13;8(1):8. doi: 10.1186/1617-9625-8-8. Tob Induc Dis. 2010. PMID: 20626883 Free PMC article.
BACKGROUND: Nicotine replacement therapy (NRT) is the most common form of smoking cessation pharmacotherapy and has proven efficacy for the treatment of tobacco dependence. Although expectations of mild adverse effects have been observed to be independent predictors of red …
BACKGROUND: Nicotine replacement therapy (NRT) is the most common form of smoking cessation pharmacotherapy and has proven efficacy for the …
A randomized clinical trial of St. John's wort for smoking cessation.
Sood A, Ebbert JO, Prasad K, Croghan IT, Bauer B, Schroeder DR. Sood A, et al. Among authors: ebbert jo. J Altern Complement Med. 2010 Jul;16(7):761-7. doi: 10.1089/acm.2009.0445. J Altern Complement Med. 2010. PMID: 20590478 Free PMC article. Clinical Trial.
INTRODUCTION: St. John's wort (SJW) is a widely used herbal supplement. The predominant mechanism(s) accounting for the activity of SJW in vivo are, however, unclear. ...Our data, in combination with data from other studies, suggest that SJW has little role in the t …
INTRODUCTION: St. John's wort (SJW) is a widely used herbal supplement. The predominant mechanism(s) accounting for the activi …
Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.
Ebbert JO, Edmonds A, Luo X, Jensen J, Hatsukami DK. Ebbert JO, et al. Nicotine Tob Res. 2010 Aug;12(8):823-7. doi: 10.1093/ntr/ntq088. Epub 2010 Jun 4. Nicotine Tob Res. 2010. PMID: 20525780 Free PMC article. Clinical Trial.
INTRODUCTION: Studies have evaluated smoking reduction with nicotine replacement therapy to reduce tobacco exposure and facilitate abstinence among cigarette smokers, but none have evaluated a reduction approach in smokeless tobacco (ST) users. ...DISCUSSION: A beha …
INTRODUCTION: Studies have evaluated smoking reduction with nicotine replacement therapy to reduce tobacco exposure and facilitate ab …
The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.
Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR, Hogan WJ, Ebbert JO, Porrata LF. Ehlers SL, et al. Among authors: ebbert jo. Bone Marrow Transplant. 2011 Feb;46(2):285-90. doi: 10.1038/bmt.2010.113. Epub 2010 May 17. Bone Marrow Transplant. 2011. PMID: 20479707 Free PMC article.
A paucity of research exists examining the potential impact of tobacco use on cancer treatment outcomes, especially among patients treated with hematopoietic SCT (HSCT). ...Of the 148 patients, 15% reported current smoking, 30% former smoking, and 55% never used tobacco
A paucity of research exists examining the potential impact of tobacco use on cancer treatment outcomes, especially among patients tr …
The association of alcohol consumption with tobacco use in Black and White college students.
Ames SC, Stevens SR, Werch CE, Carlson JM, Schroeder DR, Kiros GE, Kershaw J, Patten CA, Ebbert JO, Offord KP. Ames SC, et al. Among authors: ebbert jo. Subst Use Misuse. 2010 Jun;45(7-8):1230-44. doi: 10.3109/10826080903554192. Subst Use Misuse. 2010. PMID: 20441460
The prevalence of alcohol and tobacco use, tobacco use characteristics according to level of alcohol consumed, and percentage of students using tobacco according to type of alcoholic beverages consumed were evaluated. The interaction of race and gender with a …
The prevalence of alcohol and tobacco use, tobacco use characteristics according to level of alcohol consumed, and percentage …
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
Ebbert JO, Hays JT, Hurt RD. Ebbert JO, et al. Drugs. 2010 Apr 16;70(6):643-50. doi: 10.2165/11536100-000000000-00000. Drugs. 2010. PMID: 20394453 Free PMC article. Review.
Globally, tobacco kills almost 5 million people around the world annually. Seven first-line pharmacotherapies are currently available and recommended by the United States Public Health Service (USPHS) clinical practice guideline for treating tobacco dependence, all …
Globally, tobacco kills almost 5 million people around the world annually. Seven first-line pharmacotherapies are currently available …
Prevalence and correlates of tobacco use among middle and high school students in western Alaska.
Thomas JL, Renner CC, Patten CA, Decker PA, Utermohle CJ, Ebbert JO. Thomas JL, et al. Among authors: ebbert jo. Int J Circumpolar Health. 2010 Apr;69(2):168-80. doi: 10.3402/ijch.v69i2.17602. Epub 2010 Apr 12. Int J Circumpolar Health. 2010. PMID: 20380809
Tobacco use rates are highest among American Indians and Alaska Natives. ...No significant gender differences on tobacco use emerged for middle or high school students. CONCLUSIONS: This study documents the high tobacco use rates among youth residing in weste
Tobacco use rates are highest among American Indians and Alaska Natives. ...No significant gender differences on tobacco use e
Gabapentin for smoking cessation.
Sood A, Ebbert JO, Wyatt KD, Croghan IT, Schroeder DR, Sood R, Hays JT. Sood A, et al. Among authors: ebbert jo. Nicotine Tob Res. 2010 Mar;12(3):300-4. doi: 10.1093/ntr/ntp195. Epub 2010 Jan 15. Nicotine Tob Res. 2010. PMID: 20081039 Free PMC article. Clinical Trial.
INTRODUCTION: We conducted a preliminary proof-of-concept study evaluating gabapentin for the treatment of tobacco dependence. METHODS: Subjects (N = 80) were randomized to gabapentin (600 mg three times per day or 900 mg three times per day) or placebo. ...DISCUSSION: Alt …
INTRODUCTION: We conducted a preliminary proof-of-concept study evaluating gabapentin for the treatment of tobacco dependence. METHOD …
A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users.
Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR. Ebbert JO, et al. Addict Behav. 2010 May;35(5):522-5. doi: 10.1016/j.addbeh.2009.12.020. Epub 2010 Jan 4. Addict Behav. 2010. PMID: 20060229 Free PMC article. Clinical Trial.
Smokeless tobacco (ST) is associated with adverse health consequences yet treatment resources for ST are not widely available. ...
Smokeless tobacco (ST) is associated with adverse health consequences yet treatment resources for ST are not widely available. ...
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Ebbert JO, Wyatt KD, Zirakzadeh A, Burke MV, Hays J. Ebbert JO, et al. Int J Chron Obstruct Pulmon Dis. 2009;4:421-30. doi: 10.2147/copd.s6300. Epub 2009 Nov 29. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 20037681 Free PMC article. Review.
Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehensive tobacco treatment interventions incorporating efficacious pharmacotherapies. ...
Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehen …
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Sood A, Ebbert JO, Clark MM, Croghan IT, Schroeder DR, Hays JT. Sood A, et al. Among authors: ebbert jo. Nicotine Tob Res. 2009 Dec;11(12):1479-84. doi: 10.1093/ntr/ntp162. Epub 2009 Nov 1. Nicotine Tob Res. 2009. PMID: 19884116 Clinical Trial.
INTRODUCTION: Weight gain following tobacco abstinence is a significant barrier to cessation. Varenicline is the most effective medication for smoking cessation but does not prevent weight gain. ...
INTRODUCTION: Weight gain following tobacco abstinence is a significant barrier to cessation. Varenicline is the most effective medic …
A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR. Ebbert JO, et al. Nicotine Tob Res. 2009 Dec;11(12):1415-23. doi: 10.1093/ntr/ntp154. Epub 2009 Oct 30. Nicotine Tob Res. 2009. PMID: 19880578 Free PMC article. Clinical Trial.
INTRODUCTION: Smokeless tobacco (ST) use is associated with adverse health consequences, and effective treatments are needed. ...DISCUSSION: The 4-mg nicotine lozenge increased self-reported but not biochemically confirmed tobacco abstinence rates at 3 months. The u …
INTRODUCTION: Smokeless tobacco (ST) use is associated with adverse health consequences, and effective treatments are needed. ...DISC …
Legislating tolerance: Spain's national public smoking law.
Muggli ME, Lockhart NJ, Ebbert JO, Jiménez-Ruiz CA, Riesco Miranda JA, Hurt RD. Muggli ME, et al. Among authors: ebbert jo. Tob Control. 2010 Feb;19(1):24-30. doi: 10.1136/tc.2009.031831. Epub 2009 Oct 21. Tob Control. 2010. PMID: 19850551
Spain's law is currently being promoted by the tobacco companies in other countries as a model for smoke-free legislation. ...The Spanish National Assembly should adopt comprehensive smoke-free legislation that does not accommodate the interests of the tobacco
Spain's law is currently being promoted by the tobacco companies in other countries as a model for smoke-free legislation. ... …
Treating tobacco dependence in a medical setting.
Hurt RD, Ebbert JO, Hays JT, McFadden DD. Hurt RD, et al. Among authors: ebbert jo. CA Cancer J Clin. 2009 Sep-Oct;59(5):314-26. doi: 10.3322/caac.20031. Epub 2009 Aug 25. CA Cancer J Clin. 2009. PMID: 19706827 Free PMC article.
The US Public Health Service Guideline for Treating Tobacco Use and Dependence 2008 Update emphasizes tobacco use as a chronic medical disorder; highlights both behavioral counseling and the use of 1 or more of the 7 approved medications; and points out the utility, …
The US Public Health Service Guideline for Treating Tobacco Use and Dependence 2008 Update emphasizes tobacco use as a chronic …
Gender differences in self-reported use, perceived efficacy, and interest in future use of nicotine-dependence treatments: A cross-sectional survey in adults at a tertiary care center for nicotine dependence.
Narayanan S, Ebbert JO, Sood A. Narayanan S, et al. Among authors: ebbert jo. Gend Med. 2009 Jul;6(2):362-8. doi: 10.1016/j.genm.2009.06.002. Gend Med. 2009. PMID: 19682663
The variations in therapeutic responses highlight the need to explore gender-specific preferences for NDTs, including complementary and alternative medicine (CAM), which has become increasingly popular in the US population for the cessation of tobacco use. OBJECTIVE: The a …
The variations in therapeutic responses highlight the need to explore gender-specific preferences for NDTs, including complementary and alte …
Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline.
Hays JT, Ebbert JO, Sood A. Hays JT, et al. Among authors: ebbert jo. Mayo Clin Proc. 2009 Aug;84(8):730-5; quiz 735-6. doi: 10.1016/S0025-6196(11)60523-5. Mayo Clin Proc. 2009. PMID: 19648390 Free PMC article. Review.
In support of this goal, the US Department of Health and Human Services recently published the clinical practice guideline entitled Treating Tobacco Use and Dependence: 2008 Update. The new guideline updates the previous guidelines published in 1996 and 2000 and presents m …
In support of this goal, the US Department of Health and Human Services recently published the clinical practice guideline entitled Treating …
Open doorway to truth: legacy of the Minnesota tobacco trial.
Hurt RD, Ebbert JO, Muggli ME, Lockhart NJ, Robertson CR. Hurt RD, et al. Among authors: ebbert jo. Mayo Clin Proc. 2009 May;84(5):446-56. doi: 10.1016/S0025-6196(11)60563-6. Mayo Clin Proc. 2009. PMID: 19411441 Free PMC article. Review.
The Minnesota settlement exposed the tobacco industry's long history of deceptive marketing, advertising, and research and ultimately forced the industry to change its business practices. ...Only a few single events in the history of public health have had as dramat …
The Minnesota settlement exposed the tobacco industry's long history of deceptive marketing, advertising, and research and ult …
Feasibility of a telephone-based intervention for support persons to help smokers quit: a pilot study.
Patten CA, Petersen LR, Hughes CA, Ebbert JO, Morgenthaler Bonnema S, Brockman TA, Decker PA, Anderson KJ, Offord KP, Boness J, Pyan K, Beddow C. Patten CA, et al. Among authors: ebbert jo. Nicotine Tob Res. 2009 Apr;11(4):427-32. doi: 10.1093/ntr/ntp029. Epub 2009 Apr 8. Nicotine Tob Res. 2009. PMID: 19357315 Free PMC article. Clinical Trial.
BACKGROUND: Nonsmokers have a potentially supportive role in tobacco cessation efforts. The present study examined the feasibility, acceptability, and potential efficacy of a telephone-based intervention for nonsmoking support persons. ...
BACKGROUND: Nonsmokers have a potentially supportive role in tobacco cessation efforts. The present study examined the feasibility, a …
Combination treatment with varenicline and nicotine replacement therapy.
Ebbert JO, Burke MV, Hays JT, Hurt RD. Ebbert JO, et al. Nicotine Tob Res. 2009 May;11(5):572-6. doi: 10.1093/ntr/ntp042. Epub 2009 Apr 7. Nicotine Tob Res. 2009. PMID: 19351781
METHODS: We reviewed the clinical experience of two groups of cigarette smokers enrolled in a residential tobacco treatment program: (a) patients receiving combination treatment with varenicline and NRT (N = 104) and (b) usual-care patients receiving treatment before the r …
METHODS: We reviewed the clinical experience of two groups of cigarette smokers enrolled in a residential tobacco treatment program: …
Emerging drugs for the treatment of tobacco dependence.
Ebbert JO. Ebbert JO. Expert Opin Emerg Drugs. 2009 Mar;14(1):23-32. doi: 10.1517/14728210802623874. Expert Opin Emerg Drugs. 2009. PMID: 19278367 Review.
OBJECTIVE: To review current and emerging pharmacotherapy for the treatment of tobacco use. METHODS: Articles retrieved with searches conducted through PubMed, Pharmaprojects database, Datamonitor, the Internet, and the author's personal files. RESULTS/CONCLUSIONS: …
OBJECTIVE: To review current and emerging pharmacotherapy for the treatment of tobacco use. METHODS: Articles retrieved with searches …
Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD. Ebbert JO, et al. Nicotine Tob Res. 2009 Mar;11(3):234-9. doi: 10.1093/ntr/ntn031. Epub 2009 Feb 25. Nicotine Tob Res. 2009. PMID: 19246427 Clinical Trial.
INTRODUCTION: Varenicline and bupropion sustained release (SR) are both safe and effective for the treatment of tobacco dependence and have different mechanisms of action. Combination pharmacotherapy with these agents may increase long-term smoking abstinence rates above w …
INTRODUCTION: Varenicline and bupropion sustained release (SR) are both safe and effective for the treatment of tobacco dependence an …
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
Muggli ME, Lee K, Gan Q, Ebbert JO, Hurt RD. Muggli ME, et al. Among authors: ebbert jo. PLoS Med. 2008 Dec 23;5(12):1729-69. doi: 10.1371/journal.pmed.0050251. PLoS Med. 2008. PMID: 19108603 Free PMC article.
However, restrictions on smoking in China remain limited and ineffective. Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countr …
However, restrictions on smoking in China remain limited and ineffective. Internal tobacco industry documents show that transnational …
A randomized controlled trial of Telephone Counseling with smokeless tobacco users: the ChewFree Minnesota study.
Boyle RG, Enstad C, Asche SE, Thoele MJ, Sherwood NE, Severson HH, Ebbert J, Solberg LI. Boyle RG, et al. Among authors: ebbert j. Nicotine Tob Res. 2008 Sep;10(9):1433-40. doi: 10.1080/14622200802279872. Nicotine Tob Res. 2008. PMID: 19023834 Clinical Trial.
Although a considerable body of evidence supports telephone quit lines for smoking cessation, much less is known about the effectiveness of proactive Telephone Counseling with smokeless tobacco (ST) users. We conducted a randomized controlled trial comparing Telephone Coun …
Although a considerable body of evidence supports telephone quit lines for smoking cessation, much less is known about the effectiveness of …
Varenicline for tobacco dependence.
Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. N Engl J Med. 2008 Nov 6;359(19):2018-24. doi: 10.1056/NEJMct0800146. N Engl J Med. 2008. PMID: 18987369 Free PMC article. Review.
Gender differences among smokers receiving interventions for tobacco dependence in a medical setting.
Croghan IT, Ebbert JO, Hurt RD, Hays JT, Dale LC, Warner N, Schroeder DR. Croghan IT, et al. Among authors: ebbert jo. Addict Behav. 2009 Jan;34(1):61-7. doi: 10.1016/j.addbeh.2008.08.010. Epub 2008 Aug 31. Addict Behav. 2009. PMID: 18814974
OBJECTIVE: The purpose of this study was to assess differences between women and men receiving treatment for tobacco dependence through a clinical treatment program. METHODS: We conducted a retrospective review of clinical data collected on 2139 ambulatory and 1259 hospita …
OBJECTIVE: The purpose of this study was to assess differences between women and men receiving treatment for tobacco dependence throu …
Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue.
Muggli ME, Ebbert JO, Robertson C, Hurt RD. Muggli ME, et al. Among authors: ebbert jo. Am J Public Health. 2008 Sep;98(9):1643-50. doi: 10.2105/AJPH.2007.130963. Epub 2008 Jul 16. Am J Public Health. 2008. PMID: 18633078 Free PMC article.
The major tobacco manufacturers discovered that polonium was part of tobacco and tobacco smoke more than 40 years ago and attempted, but failed, to remove this radioactive substance from their products. Internal tobacco industry documents reveal …
The major tobacco manufacturers discovered that polonium was part of tobacco and tobacco smoke more than 40 years ago a …
The missing link in tobacco control.
Ebbert JO, Hays JT. Ebbert JO, et al. CMAJ. 2008 Jul 15;179(2):123-4. doi: 10.1503/cmaj.080855. CMAJ. 2008. PMID: 18625975 Free PMC article. No abstract available.
Predictors of smokeless tobacco abstinence.
Ebbert JO, Glover ED, Shinozaki E, Schroeder DR, Dale LC. Ebbert JO, et al. Am J Health Behav. 2008 Nov-Dec;32(6):735-40. doi: 10.5555/ajhb.2008.32.6.735. Am J Health Behav. 2008. PMID: 18442352 Free PMC article. Clinical Trial.
OBJECTIVES: To investigate predictors of tobacco abstinence among smokeless tobacco (ST) users. METHODS: Logistic regression analyses assessed characteristics associated with tobacco abstinence among ST users receiving bupropion SR. RESULTS: Older age was ass …
OBJECTIVES: To investigate predictors of tobacco abstinence among smokeless tobacco (ST) users. METHODS: Logistic regression a …
Treatment of tobacco dependence.
Burke MV, Ebbert JO, Hays JT. Burke MV, et al. Among authors: ebbert jo. Mayo Clin Proc. 2008 Apr;83(4):479-83; quiz 483-4. doi: 10.4065/83.4.479. Mayo Clin Proc. 2008. PMID: 18380994 Review.
A systematic process to identify all smokers is crucial. Because tobacco dependence is characterized by relapses and remissions, clinicians should be ready to engage smokers and reengage relapsed smokers with options for new medication strategies and additional counseling …
A systematic process to identify all smokers is crucial. Because tobacco dependence is characterized by relapses and remissions, clin …
Efficacy and safety of varenicline for smoking cessation.
Hays JT, Ebbert JO, Sood A. Hays JT, et al. Among authors: ebbert jo. Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Am J Med. 2008. PMID: 18342165 Review.
Effective treatment of nicotine addiction is essential for reducing the substantial current and predicted morbidity and mortality associated with tobacco smoking. Despite the availability of effective treatments for smoking cessation, such as nicotine replacement therapy a …
Effective treatment of nicotine addiction is essential for reducing the substantial current and predicted morbidity and mortality associated …
Smokeless tobacco reduction: preliminary study of tobacco-free snuff versus no snuff.
Hatsukami DK, Ebbert JO, Edmonds A, Li C, Lin H, Le C, Hecht SS. Hatsukami DK, et al. Among authors: ebbert jo. Nicotine Tob Res. 2008 Jan;10(1):77-85. doi: 10.1080/14622200701704897. Nicotine Tob Res. 2008. PMID: 18188748 Free PMC article. Clinical Trial.
This preliminary study examined the effects of tobacco-free snuff (intervention, n = 52) compared with no snuff (control, n = 54) for reducing tobacco use among smokeless tobacco (ST) users not interested in quitting. Both groups received behavioral instructi …
This preliminary study examined the effects of tobacco-free snuff (intervention, n = 52) compared with no snuff (control, n = 54) for …
Differences among Black and White young adults on prior attempts and motivation to help a smoker quit.
Patten CA, Brockman TA, Ames SC, Ebbert JO, Stevens SR, Thomas JL, Werch CE, Kiros GE, Kershaw JM, Carlson JM. Patten CA, et al. Among authors: ebbert jo. Addict Behav. 2008 Mar;33(3):496-502. doi: 10.1016/j.addbeh.2007.10.007. Epub 2007 Nov 4. Addict Behav. 2008. PMID: 18061363
After adjusting for gender, the results remained unchanged. Tobacco control efforts could focus on optimizing these supportive behaviors as well as expressed motivation and interest in helping a smoker to quit among young adult nonsmokers....
After adjusting for gender, the results remained unchanged. Tobacco control efforts could focus on optimizing these supportive behavi …
Changing smokeless tobacco products new tobacco-delivery systems.
Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS. Hatsukami DK, et al. Among authors: ebbert jo. Am J Prev Med. 2007 Dec;33(6 Suppl):S368-78. doi: 10.1016/j.amepre.2007.09.005. Am J Prev Med. 2007. PMID: 18021912 Review.
While the primary motives of the major tobacco companies are to maintain or increase tobacco use, some members of the public health community perceive the use of noncombusted oral tobacco products as a harm reduction tool. ...To date, limited research …
While the primary motives of the major tobacco companies are to maintain or increase tobacco use, some members of the public h …
Interventions for smokeless tobacco use cessation.
Ebbert JO, Montori V, Vickers KS, Erwin PC, Dale LC, Stead LF. Ebbert JO, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004306. doi: 10.1002/14651858.CD004306.pub3. Cochrane Database Syst Rev. 2007. PMID: 17943813 Updated. Review.
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease and cancer. ...
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including peri …
Quitline referral vs. self-help manual for tobacco use cessation in the Emergency Department: a feasibility study.
Schiebel NE, Ebbert JO. Schiebel NE, et al. Among authors: ebbert jo. BMC Emerg Med. 2007 Sep 14;7:15. doi: 10.1186/1471-227X-7-15. BMC Emerg Med. 2007. PMID: 17868444 Free PMC article.
BACKGROUND: Tobacco use counseling interventions delivered in the primary care setting are efficacious, but limited evidence exists regarding their feasibility or efficacy in the Emergency Department (ED). ED randomized controlled trials evaluating referral for outpatient …
BACKGROUND: Tobacco use counseling interventions delivered in the primary care setting are efficacious, but limited evidence exists r …
Characteristics of Air Force personnel who choose pharmacological aids for smoking cessation following an involuntary tobacco ban and tobacco control program.
Klesges RC, Klesges LM, Vander Weg MW, DeBon M, Poston WS, Ebbert J, Hays JT, Haddock CK. Klesges RC, et al. Among authors: ebbert j. Health Psychol. 2007 Sep;26(5):588-97. doi: 10.1037/0278-6133.26.5.588. Health Psychol. 2007. PMID: 17845110
OBJECTIVE: The objective of this study was to compare characteristics of smokers who did and did not report use of cessation aids as part of a tobacco control program in a military setting (n = 8994). DESIGN: The study is a longitudinal epidemiological study where the rela …
OBJECTIVE: The objective of this study was to compare characteristics of smokers who did and did not report use of cessation aids as part of …
Prevalence of alternative forms of tobacco use in a population of young adult military recruits.
Vander Weg MW, Peterson AL, Ebbert JO, Debon M, Klesges RC, Haddock CK. Vander Weg MW, et al. Among authors: ebbert jo. Addict Behav. 2008 Jan;33(1):69-82. doi: 10.1016/j.addbeh.2007.07.005. Epub 2007 Jul 13. Addict Behav. 2008. PMID: 17706889 Free PMC article.
This study examined the use of alternative tobacco products including bidis, cigars, kreteks (clove cigarettes), pipes, and smokeless tobacco in a large sample of young adult military recruits (N=31107). ...With the exception of kreteks, which did not differ …
This study examined the use of alternative tobacco products including bidis, cigars, kreteks (clove cigarettes), pipes, and sm …
Interventions for tobacco cessation in the dental setting. A systematic review.
Carr AB, Ebbert JO. Carr AB, et al. Among authors: ebbert jo. Community Dent Health. 2007 Jun;24(2):70-4. Community Dent Health. 2007. PMID: 17615820 Review.
Oral health professionals have a unique opportunity to increase tobacco abstinence rates among patients who use tobacco. OBJECTIVE: To assess the effectiveness of interventions for tobacco cessation offered to cigarette smokers and smokeless tobacco us …
Oral health professionals have a unique opportunity to increase tobacco abstinence rates among patients who use tobacco. OBJEC …
Tobacco use quitline enrollment through dental practices: a pilot study.
Ebbert JO, Carr AB, Patten CA, Morris RA, Schroeder DR. Ebbert JO, et al. J Am Dent Assoc. 2007 May;138(5):595-601. doi: 10.14219/jada.archive.2007.0229. J Am Dent Assoc. 2007. PMID: 17473036 Clinical Trial.
RESULTS: The authors enrolled 82 patients (60 in the tobacco use quitline group, 22 in the brief counseling group). At six months, the self-reported, seven-day point prevalence tobacco use abstinence rates were 25.0 percent (15 of 60 patients) in the tobacco
RESULTS: The authors enrolled 82 patients (60 in the tobacco use quitline group, 22 in the brief counseling group). At six months, th …
Treating tobacco dependence: review of the best and latest treatment options.
Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD. Ebbert JO, et al. J Thorac Oncol. 2007 Mar;2(3):249-56. doi: 10.1097/JTO.0b013e318031bca4. J Thorac Oncol. 2007. PMID: 17410050 Free article. Review.
Globally, an estimated 85% of lung cancer in men and 47% of lung cancer in women is attributable to tobacco smoking. Tobacco dependence treatment remains the most cost-effective way to prevent morbidity and mortality from lung cancer. ...Approaching the treatment of …
Globally, an estimated 85% of lung cancer in men and 47% of lung cancer in women is attributable to tobacco smoking. Tobacco d …
Nicotine lozenges for the treatment of smokeless tobacco use.
Ebbert JO, Dale LC, Severson H, Croghan IT, Rasmussen DF, Schroeder DR, Vander Weg MW, Hurt RD. Ebbert JO, et al. Nicotine Tob Res. 2007 Feb;9(2):233-40. doi: 10.1080/14622200601080349. Nicotine Tob Res. 2007. PMID: 17365754 Clinical Trial.
Nicotine lozenges have been shown to increase tobacco abstinence rates in cigarette smokers, but they have not been evaluated in smokeless tobacco (ST) users. ...Subjects completed daily tobacco withdrawal diaries, and data on lozenge use, adverse events, and …
Nicotine lozenges have been shown to increase tobacco abstinence rates in cigarette smokers, but they have not been evaluated in smok …
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD. Ebbert JO, et al. Nicotine Tob Res. 2007 Jan;9(1):43-52. doi: 10.1080/14622200601078285. Nicotine Tob Res. 2007. PMID: 17365735 Clinical Trial.
We investigated the effect of high-dose nicotine therapy on tobacco withdrawal symptoms among ST users in a randomized, controlled clinical pilot study. ...High-dose nicotine patch therapy is safe and well tolerated in this population of tobacco users....
We investigated the effect of high-dose nicotine therapy on tobacco withdrawal symptoms among ST users in a randomized, controlled cl …
Bupropion SR for the treatment of smokeless tobacco use.
Dale LC, Ebbert JO, Glover ED, Croghan IT, Schroeder DR, Severson HH, Hurt RD. Dale LC, et al. Among authors: ebbert jo. Drug Alcohol Depend. 2007 Sep 6;90(1):56-63. doi: 10.1016/j.drugalcdep.2007.02.008. Epub 2007 Mar 13. Drug Alcohol Depend. 2007. PMID: 17353101 Free PMC article. Clinical Trial.
BACKGROUND: No pharmacotherapies have been shown to increase long-term (> or = 6 months) tobacco abstinence rates among smokeless tobacco (ST) users. Bupropion SR has demonstrated potential efficacy for ST users in pilot studies. ...The primary endpoint was the 7 …
BACKGROUND: No pharmacotherapies have been shown to increase long-term (> or = 6 months) tobacco abstinence rates among smokeless …
Nicotine percentage replacement among smokeless tobacco users with nicotine patch.
Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD. Ebbert JO, et al. Drug Alcohol Depend. 2007 Jul 10;89(2-3):223-6. doi: 10.1016/j.drugalcdep.2006.12.034. Epub 2007 Feb 14. Drug Alcohol Depend. 2007. PMID: 17300878 Free PMC article. Clinical Trial.
To obtain preliminary evidence on the safety and efficacy of high dose nicotine patch therapy among smokeless tobacco (ST) users who consume > or =3 cans of ST per week, we conducted a randomized, placebo-controlled clinical trial with 42 ST users randomized to nicotine …
To obtain preliminary evidence on the safety and efficacy of high dose nicotine patch therapy among smokeless tobacco (ST) users who …
Complementary treatments for tobacco cessation: a survey.
Sood A, Ebbert JO, Sood R, Stevens SR. Sood A, et al. Among authors: ebbert jo. Nicotine Tob Res. 2006 Dec;8(6):767-71. doi: 10.1080/14622200601004109. Nicotine Tob Res. 2006. PMID: 17132524
A total of 67% of the patients reported interest in future use of CAM for tobacco cessation. The treatments of greatest interest for use in the future were hypnosis, herbal products, acupuncture, relaxation, and massage therapy. Female gender, previous use of conven …
A total of 67% of the patients reported interest in future use of CAM for tobacco cessation. The treatments of greatest interest for …
Smokeless tobacco brand switching: a means to reduce toxicant exposure?
Hatsukami DK, Ebbert JO, Anderson A, Lin H, Le C, Hecht SS. Hatsukami DK, et al. Among authors: ebbert jo. Drug Alcohol Depend. 2007 Mar 16;87(2-3):217-24. doi: 10.1016/j.drugalcdep.2006.08.021. Epub 2006 Sep 20. Drug Alcohol Depend. 2007. PMID: 16996230 Free PMC article. Clinical Trial.
The purpose of this study was to examine the effects of smokeless tobacco (ST) brand switching on biomarkers of ST exposure and on ST use. ...During the intervention, Copenhagen or Kodiak ST users were asked to switch to products that were sequentially lower in nico …
The purpose of this study was to examine the effects of smokeless tobacco (ST) brand switching on biomarkers of ST exposure and on ST …
The Fagerstrom Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).
Ebbert JO, Patten CA, Schroeder DR. Ebbert JO, et al. Addict Behav. 2006 Sep;31(9):1716-21. doi: 10.1016/j.addbeh.2005.12.015. Epub 2006 Jan 31. Addict Behav. 2006. PMID: 16448783 Free PMC article. Clinical Trial.
Few nicotine dependence measures have been developed for smokeless tobacco (ST) users. Existing measures are limited by the requirement to rate the nicotine content of ST brands for which data is scarce or non-existent. ...
Few nicotine dependence measures have been developed for smokeless tobacco (ST) users. Existing measures are limited by the requireme …
Interventions for tobacco cessation in the dental setting.
Carr AB, Ebbert JO. Carr AB, et al. Among authors: ebbert jo. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005084. doi: 10.1002/14651858.CD005084.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437517 Updated. Review.
BACKGROUND: Tobacco use has significant adverse effects on oral health. Oral health professionals in the dental office or community setting have a unique opportunity to increase tobacco abstinence rates among tobacco users. OBJECTIVES: This review assesses th …
BACKGROUND: Tobacco use has significant adverse effects on oral health. Oral health professionals in the dental office or community s …
Predictors of smokeless tobacco initiation in a young adult military cohort.
Ebbert JO, Haddock CK, Vander Weg M, Klesges RC, Poston WS, DeBon M. Ebbert JO, et al. Am J Health Behav. 2006 Jan-Feb;30(1):103-12. doi: 10.5555/ajhb.2006.30.1.103. Am J Health Behav. 2006. PMID: 16430325
OBJECTIVE: To identify predictors of smokeless tobacco (ST) initiation among young adults. METHODS: A military cohort (N=28,229) was analyzed to identify variables associated with ST initiation. ...
OBJECTIVE: To identify predictors of smokeless tobacco (ST) initiation among young adults. METHODS: A military cohort (N=28,229) was …
Measuring nicotine dependence among smokeless tobacco users.
Thomas JL, Ebbert JO, Patten CA, Dale LC, Bronars CA, Schroeder DR. Thomas JL, et al. Among authors: ebbert jo. Addict Behav. 2006 Sep;31(9):1511-21. doi: 10.1016/j.addbeh.2005.11.005. Epub 2006 Jan 4. Addict Behav. 2006. PMID: 16386854 Clinical Trial.
FTQ-ST total scores were positively correlated with serum cotinine (Spearman's r=0.40, P<0.001), amount of tobacco used (r=0.51 and r=0.41 for average dips/chews per day; average tins/pouches per week, respectively, P<0.001), and a reduced likelihood of abstin …
FTQ-ST total scores were positively correlated with serum cotinine (Spearman's r=0.40, P<0.001), amount of tobacco used (r= …
Iqmik: a form of smokeless tobacco used among Alaska natives.
Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM. Renner CC, et al. Among authors: ebbert jo. Am J Health Behav. 2005 Nov-Dec;29(6):588-94. doi: 10.5555/ajhb.2005.29.6.588. Am J Health Behav. 2005. PMID: 16336113
OBJECTIVES: To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska. ...CONCLUSION: The high alkalinity of Iqmik may contribute to the higher rates of tobacco use in this population....
OBJECTIVES: To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska. ... …
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates.
Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP. Hurt RD, et al. Among authors: ebbert jo. J Matern Fetal Neonatal Med. 2005 Apr;17(4):281-9. doi: 10.1080/14767050500123731. J Matern Fetal Neonatal Med. 2005. PMID: 16147838
RESULTS: At delivery, there were 22 subjects who reported using only Iqmik, and 10 who used other tobacco products. Subjects who reported using only Iqmik prior to delivery had higher concentrations of cotinine (167+/-116 vs. 81+/-100) in maternal blood (rank sum te …
RESULTS: At delivery, there were 22 subjects who reported using only Iqmik, and 10 who used other tobacco products. Subjects w …
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, Taylor WR, Marks RS, Deschamps C, Swensen SJ, Wieben ED, Cunningham JM, Melton LJ, de Andrade M. Yang P, et al. Among authors: ebbert jo. Chest. 2005 Jul;128(1):445-52. doi: 10.1378/chest.128.1.445. Chest. 2005. PMID: 16002971
Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, and family history of lung cancer RESULTS: Sex and ethnicity were comparable between case patients and control subjects, but case patients we …
Multivariable logistic regression models tested the independent and interactive effects of PI1, ELA2, tobacco smoke exposure, COPD, a …
Motivation for stopping tobacco use among emergency department patients.
Klinkhammer MD, Patten CA, Sadosty AT, Stevens SR, Ebbert JO. Klinkhammer MD, et al. Among authors: ebbert jo. Acad Emerg Med. 2005 Jun;12(6):568-71. doi: 10.1197/j.aem.2004.11.027. Acad Emerg Med. 2005. PMID: 15930410 Free article.
The authors assessed the level of motivation to quit tobacco use among a general population of ED patients; the proportion who receive tobacco-use assessments, information, and interventions from ED providers; and the desired timing of tobacco-use interventio …
The authors assessed the level of motivation to quit tobacco use among a general population of ED patients; the proportion who receiv …
A survey of characteristics of smokeless tobacco users in a treatment program.
Ebbert JO, Klinkhammer MD, Stevens SR, Rowland LC, Offord KP, Ames SC, Dale LC. Ebbert JO, et al. Am J Health Behav. 2005 Jan-Feb;29(1):25-35. doi: 10.5993/ajhb.29.1.3. Am J Health Behav. 2005. PMID: 15604048
OBJECTIVE: To determine the characteristics and outcomes of smokeless tobacco (ST) users receiving interventions in an outpatient tobacco-dependence treatment program. ...CONCLUSIONS: Enhancing confidence in their ability to quit, managing stress, prescribing buprop …
OBJECTIVE: To determine the characteristics and outcomes of smokeless tobacco (ST) users receiving interventions in an outpatient …
Smokeless tobacco: an emerging addiction.
Ebbert JO, Carr AB, Dale LC. Ebbert JO, et al. Med Clin North Am. 2004 Nov;88(6):1593-605. doi: 10.1016/j.mcna.2004.06.003. Med Clin North Am. 2004. PMID: 15464115 Review.
Smokeless tobacco (ST) use is an important health issue in the United States, and chronic use leads to significant morbidity. ...Clinical treatment of ST users requires an understanding of the unique characteristics of ST. This article reviews ST products, epidemiol …
Smokeless tobacco (ST) use is an important health issue in the United States, and chronic use leads to significant morbidity. ...Clin …
Interventions for smokeless tobacco use cessation.
Ebbert JO, Rowland LC, Montori V, Vickers KS, Erwin PC, Dale LC, Stead LF. Ebbert JO, et al. Cochrane Database Syst Rev. 2004;(3):CD004306. doi: 10.1002/14651858.CD004306.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266527 Updated. Review.
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and health problems including periodontal disease and oral cancer OBJECTIVES: To assess the effects of behavioural and pharmacotherapeutic interventions to treat ST use. SEARCH STRATEGY: We searched t …
BACKGROUND: Use of smokeless tobacco (ST) can lead to nicotine addiction and health problems including periodontal disease and oral c …
Glutathione pathway genes and lung cancer risk in young and old populations.
Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. Yang P, et al. Among authors: ebbert jo. Carcinogenesis. 2004 Oct;25(10):1935-44. doi: 10.1093/carcin/bgh203. Epub 2004 Jun 10. Carcinogenesis. 2004. PMID: 15192016
Multiple enzymes with overlapping functions and shared substrates in the glutathione (GSH) metabolic pathway have been associated with host susceptibility to tobacco smoke carcinogens and in lung cancer etiology. However, few studies have investigated the differing and int …
Multiple enzymes with overlapping functions and shared substrates in the glutathione (GSH) metabolic pathway have been associated with host …
Residential treatment for smokeless tobacco use: a case series.
Ebbert JO, Dale LC, Vickers KS, Gauvin TR, Bunge NE, Hurt RD. Ebbert JO, et al. J Subst Abuse Treat. 2004 Jun;26(4):261-7. doi: 10.1016/j.jsat.2004.01.008. J Subst Abuse Treat. 2004. PMID: 15182890 Clinical Trial.
We developed and implemented a novel 8-day residential treatment program for smokeless tobacco (ST) use. A multidisciplinary team delivered behavioral treatment, nicotine patches were adjusted to achieve 100% replacement of baseline peak serum nicotine concentrations, and …
We developed and implemented a novel 8-day residential treatment program for smokeless tobacco (ST) use. A multidisciplinary team del …
Environmental tobacco smoke exposure in women with lung cancer.
de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P. de Andrade M, et al. Among authors: ebbert jo. Lung Cancer. 2004 Feb;43(2):127-34. doi: 10.1016/j.lungcan.2003.08.025. Lung Cancer. 2004. PMID: 14739032
CONCLUSIONS: Over 95% of women with lung cancer in our study were exposed to tobacco smoke through a personal smoking history or ETS. The cumulative amount of tobacco smoke exposure may be significantly underestimated if only personal smoking history is considered. …
CONCLUSIONS: Over 95% of women with lung cancer in our study were exposed to tobacco smoke through a personal smoking history or ETS. …
Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.
Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Ebbert JO, et al. Addict Behav. 2004 Feb;29(2):349-55. doi: 10.1016/j.addbeh.2003.08.046. Addict Behav. 2004. PMID: 14732423
Unlike cigarette smokers, spit tobacco (ST) users absorb a significant amount of nicotine through the gastrointestinal tract while swallowing tobacco juice. ...To investigate this question, we correlated nicotine and cotinine concentrations with clinical measures of …
Unlike cigarette smokers, spit tobacco (ST) users absorb a significant amount of nicotine through the gastrointestinal tract while sw …
Bupropion sustained release for treatment of tobacco dependence.
Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. Mayo Clin Proc. 2003 Aug;78(8):1020-4; quiz 1024. doi: 10.4065/78.8.1020. Mayo Clin Proc. 2003. PMID: 12911050 Review.
Tobacco use is a global pandemic. The most common pharmacological treatments of tobacco use and dependence include nicotine replacement therapy and nonnicotine medications. ...This article reviews the evidence of efficacy and common adverse effects of bupropion SR a
Tobacco use is a global pandemic. The most common pharmacological treatments of tobacco use and dependence include nicotine re
Treatments for spit tobacco use: a quantitative systematic review.
Ebbert JO, Rowland LC, Montori VM, Vickers KS, Erwin PJ, Dale LC. Ebbert JO, et al. Addiction. 2003 May;98(5):569-83. doi: 10.1046/j.1360-0443.2003.00378.x. Addiction. 2003. PMID: 12751971 Review.
AIMS: Spit tobacco use is prevalent in the United States and is associated with adverse health consequences. ...Nicotine replacement therapy with patch or gum increased point prevalence tobacco abstinence at 6 months (OR 1.3; 95% CI, 1.0-1.6). Behavioral interventio …
AIMS: Spit tobacco use is prevalent in the United States and is associated with adverse health consequences. ...Nicotine replacement …
Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.
Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. CNS Drugs. 2003;17(2):71-83. doi: 10.2165/00023210-200317020-00001. CNS Drugs. 2003. PMID: 12521356 Review.
Tobacco use, particularly cigarette smoking, is now a global pandemic. ...The antidepressant with the greatest weight of evidence for efficacy in the treatment of tobacco dependence is bupropion. Sustained-release bupropion is approved for the treatment of tobacc
Tobacco use, particularly cigarette smoking, is now a global pandemic. ...The antidepressant with the greatest weight of evidence for
Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
Dale LC, Ebbert JO, Schroeder DR, Croghan IT, Rasmussen DF, Trautman JA, Cox LS, Hurt RD. Dale LC, et al. Among authors: ebbert jo. Nicotine Tob Res. 2002 Aug;4(3):267-74. doi: 10.1080/14622200210153821. Nicotine Tob Res. 2002. PMID: 12215235 Clinical Trial.
The primary endpoint was 1-week, biochemically confirmed point-prevalence tobacco abstinence rate at the end of treatment (week 12). Nicotine withdrawal symptoms and weight change were assessed. At the end of 12 weeks of therapy, the point-prevalence tobacco abstine …
The primary endpoint was 1-week, biochemically confirmed point-prevalence tobacco abstinence rate at the end of treatment (week 12). …
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.
Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Moyer TP, et al. Among authors: ebbert jo. Clin Chem. 2002 Sep;48(9):1460-71. Clin Chem. 2002. PMID: 12194923
Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatment success. METHODS: The procedure was designed to quantify nicotine, cotinine, trans-3'-hydroxycotinine, anabasine, and nornicotine in hum …
Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatm …
Tobacco use outcomes among patients with lung cancer treated for nicotine dependence.
Sanderson Cox L, Patten CA, Ebbert JO, Drews AA, Croghan GA, Clark MM, Wolter TD, Decker PA, Hurt RD. Sanderson Cox L, et al. Among authors: ebbert jo. J Clin Oncol. 2002 Aug 15;20(16):3461-9. doi: 10.1200/JCO.2002.10.085. J Clin Oncol. 2002. PMID: 12177107
PURPOSE: There is a current lack of consensus about the effectiveness of nicotine dependence treatment for cancer patients. This retrospective study examined the 6-month tobacco abstinence rate among lung cancer patients treated clinically for nicotine dependence. ...The i …
PURPOSE: There is a current lack of consensus about the effectiveness of nicotine dependence treatment for cancer patients. This retrospecti …
Preventing lung cancer by stopping smoking.
Hurt RD, Ebbert JO. Hurt RD, et al. Among authors: ebbert jo. Clin Chest Med. 2002 Mar;23(1):27-36, vii. doi: 10.1016/s0272-5231(03)00074-1. Clin Chest Med. 2002. PMID: 11901917 Review.
Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in t …
Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of eff …
Tobacco use outcomes of adolescents treated clinically for nicotine dependence.
Patten CA, Ames SC, Ebbert JO, Wolter TD, Hurt RD, Gauvin TR. Patten CA, et al. Among authors: ebbert jo. Arch Pediatr Adolesc Med. 2001 Jul;155(7):831-7. doi: 10.1001/archpedi.155.7.831. Arch Pediatr Adolesc Med. 2001. PMID: 11434853
OBJECTIVE: To evaluate the tobacco use outcomes and baseline characteristics of adolescents treated for nicotine dependence. ...MAIN OUTCOME MEASURES: Self-reported 7-day point-prevalence abstinence from tobacco at 6 and 12 months, and 30-day point-prevalence tob
OBJECTIVE: To evaluate the tobacco use outcomes and baseline characteristics of adolescents treated for nicotine dependence. ...MAIN …
Treatment of nicotine dependence.
Dale LC, Ebbert JO, Hays JT, Hurt RD. Dale LC, et al. Among authors: ebbert jo. Mayo Clin Proc. 2000 Dec;75(12):1311-6. doi: 10.4065/75.12.1311. Mayo Clin Proc. 2000. PMID: 11126841 Review.